Erythema of rosacea: a new and effective treatment

被引：0
|
作者：
Hougeir, F. G.
机构：
[1] Atlanta - GA 30328-4274
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2014年 / 141卷
关键词：
Rosacea; Erythema; Brimonidine; TARTRATE GEL 0.5-PERCENT; SEVERE FACIAL ERYTHEMA; STANDARD MANAGEMENT OPTIONS; BRIMONIDINE; MODERATE; EFFICACY; GLAUCOMA; SAFETY; IMPACT; LIFE;
D O I：
10.1016/S0151-9638(14)70155-3
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Until recently, our rosacea patients have had to suffer of their erythema with limited effective treatments. Mirvaso (R) (Brimonidine tartrate 0.5%, Brimonidine 3mg/g) is a new medication, indicated for the treatment of the erythema of rosacea. The phase III pivotal and long term studies showing the efficacy and tolerability of Mirvaso (R) are summarized. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：S169 / S174
页数：6
相关论文
共 50 条
  • [1] Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options
    Steinhoff, Martin
    Schmelz, Martin
    Schauber, Juergen
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (05) : 579 - +
  • [2] Oxymetazoline hydrochloride cream for facial erythema associated with rosacea
    Patel, Nupur U.
    Shukla, Shweta
    Zaki, Jessica
    Feldman, Steven R.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (10) : 1049 - 1054
  • [3] Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol
    Pietschke, Katharina
    Schaller, Martin
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (03) : 310 - 313
  • [4] Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea
    Tong, Lana X.
    Moore, Angela Yen
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 567 - 577
  • [5] Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial
    Wang, Ben
    Huang, Yingxue
    Tang, Yan
    Zhao, Zhixiang
    Shi, Wei
    Jian, Dan
    Liu, Fangfen
    Gao, Qiong
    Wang, Peiru
    Yang, Jie
    Li, Lin
    Xie, Hongfu
    Li, Ji
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (06) : 1300 - 1307
  • [6] New Agents for the Treatment of Erythematotelangiectatic Rosacea
    Fowler, Joseph, Jr.
    CUTIS, 2014, 94 (01): : 6 - 7
  • [7] Laser treatment of erythema and telangiectasia associated with rosacea
    Clark, SM
    Lanigan, SW
    Marks, R
    LASERS IN MEDICAL SCIENCE, 2002, 17 (01) : 26 - 33
  • [8] Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema
    Fowler, J.
    Tan, J.
    Jackson, J. M.
    Meadows, K.
    Jones, T.
    Jarratt, M.
    Leoni, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (03) : 474 - 481
  • [9] Advances in the Treatment of Rosacea-Associated Facial Erythema
    Wang Yun
    Guo ShuPing
    Cao Jun
    Ren Ling
    国际皮肤性病学杂志（英文）, 2022, 05 (03)
  • [10] BOTULINUM TOXIN FOR THE TREATMENT OF REFRACTORY ERYTHEMA AND FLUSHING OF ROSACEA
    Park, Kui Young
    No, Yeon A.
    Suh, Joon Hyuk
    Jeong, Se Yeong
    Kim, Beom Joon
    Kim, Myeung Nam
    Hong, Chang Kwun
    JOURNAL OF DERMATOLOGY, 2014, 41 : 106 - 106
12345